Long-term Use of Prograf May Increase Risk of Lymphoma in MG Patients, Case Report Suggests
Researchers have found that the long-term use of the immunosuppressive drug Prograf (tacrolimus) may contribute to the development of lymphoma in patients with myasthenia gravis (MG). This finding resulted from a case report published in Internal Medicine, the journal of the Japanese Society of Internal Medicine. Myasthenia gravis…